Luigi Mangione acknowledged in court last Friday that he had fatally shot Brian Thompson, a health insurance executive, and pleaded guilty to two federal charges related to stalking the CEO with the intent to kill. Mangione, dressed in beige prison attire, calmly admitted to the shooting in Manhattan, expressing disdain for the U.S. health insurance system in a prepared statement.
Thompson’s widow and other family members were present in the courtroom when Mangione confessed to the crime, leading to an emotional reaction from Thompson’s widow, who was comforted by others. The guilty plea by Mangione circumvents a federal trial in the high-profile case involving the killing of the 50-year-old UnitedHealthcare CEO, which drew widespread condemnation but highlighted public frustration with health insurance industry practices.
At 28 years old, Mangione entered his plea without a plea agreement with federal prosecutors, risking a potential life sentence, the maximum punishment, at his sentencing scheduled for December 18. U.S. District Judge Margaret Garnett may consider Mangione’s guilty plea as a mitigating factor during sentencing.
The guilty plea also allowed Mangione’s legal team to file a motion to dismiss separate state charges of murder and weapons violations, arguing against double jeopardy under New York state law. Despite Mangione’s plea, Manhattan U.S. Attorney Jamie McDonald emphasized that no special treatment would be given to Mangione, stating firmly that no grievance or ideology justifies murder.
Thompson’s family welcomed the plea as a crucial step towards justice and expressed hope that the sentencing would reflect the severity of the crime. Thompson, who previously led UnitedHealth Group’s insurance division, was fatally shot outside a hotel during an investor conference, leading to widespread media coverage and a manhunt for the suspect.
In court, Mangione revealed challenges he faced with his insurance coverage after a back injury, citing dissatisfaction with the response time. He admitted to impersonating an investor to gather information on Thompson’s whereabouts, eventually leading him to create a firearm using a 3D printer and traveling to New York with the intent to kill.
UnitedHealth Group expressed gratitude to law enforcement for apprehending Thompson’s killer. Mangione had previously pleaded not guilty to federal charges but had murder and weapons charges dismissed due to legal technicalities. The upcoming trial in the state case is slated for September, with Mangione potentially facing a lengthy prison sentence if convicted.
As legal proceedings continue, the defence and prosecution are at odds over the application of double jeopardy laws in New York, with the defence arguing that facing another trial would violate Mangione’s constitutional rights. State prosecutors face challenges in justifying a second trial based on the similarities between the stalking and murder charges.

